Skip to main content

Table 1 Baseline demographic and clinical characteristics of patients evaluated for pulmonary rehabilitation (n = 71)

From: Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study

Variables

Age (mean ± SD, years)

60.6 ± 8.8

Gender (%)

 

 Male

76.1 (n = 54)

 Female

23.9 (n = 17)

BMI (mean ± SD, kg/m2)

25.8 ± 8.8

Smokers (%)

 

 Current smokers

14.1 (n = 10)

 Former smokers

56.3 (n = 40)

 Non smokers

29.6 (n = 21)

Type of thoracic cancer (%)

 

 Adenocarcinoma

42.3 (n = 30)

 Squamous cell carcinoma

16.9 (n = 12)

 Small cell carcinoma

5.6 (n = 4)

 Mesothelioma (MPM)

23.9 (n = 17)

 Others

11.3 (n = 8)

Lung cancer TNM stage (%) excluding MPM

 

 stage IB

1.9 (n = 1)

 stage IIA

5.6 (n = 3)

 stage IIB

3.7 (n = 2)

 stage IIIA

16.7 (n = 9)

 stage IIIB

11.1 (n = 6)

 stage IV

61.1 (n = 33)

VSRQ total score (mean ± SD)

46.3 ± 17

HAD scale

 

 Anxiety score (median + IQR)

7 [5–10]

 Depression score (median + IQR)

6 [3–10]

  1. For quantitative data, results are expressed as mean ± standard deviation (SD) or median with interquartile range (IQR) according to distribution of data. SD standard deviation, BMI body mass index, MPM malignant pleural mesothelioma VSRQ visual simplified respiratory questionnaire global score ranging from 80 (best health status) to 0 (poorest health status) [15], HAD Hospital Anxiety and Depression scale ranging from 0 (best psychological status) to 42 (worse psychological status) [17], IQR interquartile range